Back
Keros Therapeutics Stock Predictions
Sell
20
KROS
Keros Therapeutics
Last Price:
54.03
Seasonality Move:
-7.87%
7 Day Trial
ALL ACCESS PASS
$
7
Keros Therapeutics Stock Forecast
- Over the next 52 weeks, Keros Therapeutics has on average historically risen by 27.4% based on the past 4 years of stock performance.
- Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Keros Therapeutics Stock Undervalued?
The current Keros Therapeutics [KROS] share price is $54.40. The Score for KROS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Keros Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Keros Therapeutics has on average historically risen by 27.4% based on the past 4 years of stock performance.
Keros Therapeutics Stock Rating
Sell
20
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics overpriced?
- Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Keros Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com
52-Week Data
52-Week High:
73.00
52-Week Low:
27.02
Prediction Charts
Market Cap:
1.96B
Price in USD:
54.40
Volume:
198.98K
Beta:
1.21
Technical Analysis
SMA50:
61.47
SMA100:
57.94
SMA200:
45.32
52-Wk Change:
15.88%
Stock Predictions
-
Is Keros Therapeutics stock public?
Yes, Keros Therapeutics is a publicly traded company. -
What is the Keros Therapeutics stock quote today?
The Keros Therapeutics stock price is 54.40 USD today. -
How to buy Keros Therapeutics stock online?
You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-26 | 54.68 | 57.86 | 58.45 | 53.69 |
Apr-29 | 58.39 | 58.62 | 59.28 | 57.49 |
Apr-30 | 57.66 | 56.31 | 59.67 | 56.22 |
May-1 | 56.66 | 57.72 | 58.98 | 55.83 |
May-2 | 58.34 | 57.08 | 58.50 | 56.69 |
May-3 | 57.32 | 60.57 | 62.19 | 57.32 |
May-6 | 60.32 | 60.26 | 61.96 | 59.80 |
May-7 | 61.18 | 58.68 | 61.18 | 57.32 |
May-8 | 56.56 | 58.24 | 59.75 | 56.56 |
May-9 | 59.70 | 57.77 | 60.36 | 57.39 |
May-10 | 58.06 | 54.27 | 58.43 | 53.59 |
May-13 | 54.87 | 54.00 | 55.03 | 53.20 |
May-14 | 54.78 | 52.80 | 55.53 | 52.50 |
May-15 | 53.89 | 54.40 | 54.88 | 53.24 |
Keros Therapeutics Earnings
Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Keros Therapeutics Forecast Revenue Growth
Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.04 per share, an increase this year of $0.25 per share, and a decrease next year of $0.39 per share.
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.